Clinical Trial Update: Multiple Dose Study of SHR4640 in Healthy Subjects [Phase 1]

View source ↗

Summary

A Phase 1 multiple-dose study of SHR4640 in healthy subjects has completed, assessing safety and pharmacokinetics in the context of gout and hyperuricemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout
• Hyperuricemia

Drugs mentioned

• SHR4640

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Gout; Hyperuricemia | Phase 1 | Status: COMPLETED